We integrate technologies to reverse the pathology of pulmonary hypertension and other diseases
We seek to uncover molecular pathways that lead to developmental and inflammatory mechanisms of vascular pathobiology, particularly pulmonary hypertension.
Dr. Rabinovitch and Dr. Bland are proud to lead a team of talented individuals working together to advance cardiopulmonary research.
Publications stemming from our laboratory.
Links to Stanford and external affiliates/resources
News & Highlights
Events at the Stanford Cardiovascular Institute (CVI)
Frontiers in Cardiovascular Science seminars
Pulmonary Hypertension Grand Rounds
MED223: Cardiovascular Research and Medicine
17th annual Race Against PH on November 5, 2017